Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borui Tang

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Thrombosis Research|January 9, 2022
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trialsXinrui Wang, Borui Tang, Meng Zhou, et al.
Journal of Clinical Pharmacy and Therapeutics|December 23, 2021
Clinical practice guidelines for management of dual antiplatelet therapy in patients with noncardiac surgery: A critical appraisal using the AGREE II instrumentXin Wang, Borui Tang, Ying Liu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 16, 2025
Tenuigenin targets Trim31 and NF-κB pathway to protect dopaminergic neurons in Parkinson's disease miceDi Zhang, Chen Xu, Borui Tang, et al.
Cell Reports|September 22, 2021
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferationTanjing Song, Qingli Zou, Yingying Yan, et al.
Nature Chemical Biology|June 26, 2025
Publisher Correction: Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Nature Communications|January 28, 2026
Author Correction: UKB-MDRMF: a multi-disease risk and multimorbidity framework based on UK biobank dataYukang Jiang, Bingxin Zhao, Xiaopu Wang, et al.
Nature Chemical Biology|June 13, 2025
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Nature Communications|April 22, 2025
UKB-MDRMF: a multi-disease risk and multimorbidity framework based on UK biobank dataYukang Jiang, Bingxin Zhao, Xiaopu Wang, et al.
Research (Washington, D.C.)|July 8, 2025
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1Borui Tang, Yuting Wang, Liping Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 10, 2025
Novel Quaternary Ammonium Salt-Linked STING Agonist Antibody-Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off-Target ToxicityYu Long, Borui Tang, Fei Xie, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Thrombosis Research|January 9, 2022
Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trialsXinrui Wang, Borui Tang, Meng Zhou, et al.
Journal of Clinical Pharmacy and Therapeutics|December 23, 2021
Clinical practice guidelines for management of dual antiplatelet therapy in patients with noncardiac surgery: A critical appraisal using the AGREE II instrumentXin Wang, Borui Tang, Ying Liu, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 16, 2025
Tenuigenin targets Trim31 and NF-κB pathway to protect dopaminergic neurons in Parkinson's disease miceDi Zhang, Chen Xu, Borui Tang, et al.
Cell Reports|September 22, 2021
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferationTanjing Song, Qingli Zou, Yingying Yan, et al.
Nature Chemical Biology|June 26, 2025
Publisher Correction: Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Nature Communications|January 28, 2026
Author Correction: UKB-MDRMF: a multi-disease risk and multimorbidity framework based on UK biobank dataYukang Jiang, Bingxin Zhao, Xiaopu Wang, et al.
Nature Chemical Biology|June 13, 2025
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Nature Communications|April 22, 2025
UKB-MDRMF: a multi-disease risk and multimorbidity framework based on UK biobank dataYukang Jiang, Bingxin Zhao, Xiaopu Wang, et al.
Research (Washington, D.C.)|July 8, 2025
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1Borui Tang, Yuting Wang, Liping Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 10, 2025
Novel Quaternary Ammonium Salt-Linked STING Agonist Antibody-Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off-Target ToxicityYu Long, Borui Tang, Fei Xie, et al.
Pageof 3